Skip to content

Chemotherapy and cognitive functioning in breast cancer patients and the effects on patients' quality of life and health care consuption

Chemotherapy and cognitive functioning in breast cancer patients and the effects on patients' quality of life and health care consuption - Effect of chemotherapy and cognition on breast cancer patients' QOL and HCC

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33665
Enrollment
300
Registered
2008-06-16
Start date
2009-01-08
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Breast Neoplasm

Interventions

None listed

Sponsors

Sint Elisabeth Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Women visiting the outpatieny clinics with a suspicion of breast cancer

Exclusion criteria

Exclusion criteria: disease recurrence at baseline or metastases; history of neuropsychologic and/ or psychiatric signs or symptoms that lead to deviant neuropsychologic test results (e.g. dementia); the use of medication that may lead to deviant neuropsychological results; alcohol and drug addiction; poor expression in the dutch language

Design outcomes

Primary

MeasureTime frame
Primary study parameters: subjective cognitive dysfunction, objective cognitive dysfunction Outcome of the study: quality of life, health care consumption

Secondary

MeasureTime frame
N.A.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)